Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Frauke
Frauke Bentzien, San Francisco, CA US
| Patent application number | Description | Published |
|---|---|---|
| 20110301188 | Synergistic Effects Between Sphingosine-1-Phosphate Receptor Antagonists and Antimicrotubule Agents - This invention is based on the discovery that the administration of a sphingosine-1-phosphate receptor antagonist (S1P) and at least one chemotherapeutic agent selected from the the group of antimicrotubule agents provides an unexpectedly superior treatment for cancer. Antimicrobial agents such as the taxane compounds are known in the art, for example, paclitaxel (available as TAXOL® from Bristol-Myers Squibb, Princeton, N.J.), docetaxel (available as TAXOTERE® from Sanofi-aventis, Bridgewater, N.J.) and the like and other compounds that act as antimicrotubule agents, such as Vincristine (ONCOVIN®, VINCASAR PFS®, VCR), Vinblastin (VELBAN®, VELSAR®) and Vinorelbine, and similar compounds. The present invention also provides methods of modulating the growth of selected cell populations, such as cancer cells, by administering a therapeutically effective amount of at least one sphingosine-1-phosphate 1 (S1P1R) receptor antagonists, and at least one antimicrotubule agent. | 12-08-2011 |
Frauke Goeman, Roma IT
| Patent application number | Description | Published |
|---|---|---|
| 20110197288 | Transgenic animal for screening of compounds that modulate cell proliferation, and its use in the pharmaceutical field - The present invention relates to a transgenic non-human mammalian animal whose genome incorporates a biosensor of the activity of modulators of cell proliferation consisting of a DNA sequence that comprises the luciferase reporter transgene ligated downstream of a promoter sequence of the CYCB2 gene, this sequence promoter/reporter being flanked by HS4 insulator sequences at each of its 3′ and 5′ sides. | 08-11-2011 |
Frauke Jordt, Eppstein DE
| Patent application number | Description | Published |
|---|---|---|
| 20080280182 | POLYMER MEMBRANE, METHOD FOR THE PRODUCTION AND USE THEREOF - The present invention relates to an acid-doped polymer membrane based on polyazoles. The acid-doped polymer membrane can be used in a variety of applications because of its excellent mechanical properties and is useful as polymer electrolyte membrane (PEM) in PEM fuel cells. A doped polymer membrane based on polyazoles is obtained by a process comprising the steps of: A) casting a film using a solution of polymers based on polyazoles in a polar, aprotic organic solvent; B) drying the film formed in step A) until it is self-supporting; C) treating the film obtained in step B) with a treatment liquid at a temperature in the range from room temperature to the boiling point of the treatment liquid; D) drying and/or dabbing the film treated according to step C) to remove the treatment liquid from step C); and E) doping the film treated according to step D) with a doping agent. | 11-13-2008 |
| 20100164148 | POLYMER MEMBRANE, METHOD FOR THE PRODUCTION AND USE THEREOF - The present invention relates to an acid-doped polymer membrane based on polyazoles. The acid-doped polymer membrane can be used in a variety of applications because of its excellent mechanical properties and is useful as polymer electrolyte membrane (PEM) in PEM fuel cells. A doped polymer membrane based on polyazoles is obtained by a process comprising the steps of: A) casting a film using a solution of polymers based on polyazoles in a polar, aprotic organic solvent; B) drying the film formed in step A) until it is self-supporting; C) treating the film obtained in step B) with a treatment liquid at a temperature in the range from room temperature to the boiling point of the treatment liquid; D) drying and/or dabbing the film treated according to step C) to remove the treatment liquid from step C); and E) doping the film treated according to step D) with a doping agent. | 07-01-2010 |
Frauke Pohlki, Mutterstadt DE
| Patent application number | Description | Published |
|---|---|---|
| 20100273767 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF - The present application relates to 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2 -a][1,4]benzodiazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,5]benzodiazepine, 2,3,4,4a,5,6,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a,5,6,7 -octahydropyrazino[1,2-a][1]benzazepine, 1,2,3,4,4a,5-hexahydro-7H-pyrazino[1,2 -a][4,1]benzoxazepine, and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[2,1-d][1,5]benzoxazepine, and 5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4]diazepine derivatives of formula (I) | 10-28-2010 |
| 20110130382 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF - The present application relates to 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,4]benzodiazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1,5]benzodiazepine, 2,3,4,4a,5,6,7,11b-octahydro-1H-pyrido[3,4-d][2]benzazepine, 1,2,3,4,4a,5,6,7-octahydropyrazino[1,2-a][1]benzazepine, 1,2,3,4,4a,5-hexahydro-7H-pyrazino[1,2-a][4,1]benzoxazepine, and 2,3,4,4a,5,6-hexahydro-1H-pyrazino[2,1-d][1,5]benzoxazepine, and 5,6,7,7a,8,9,10,11-octahydropyrazino[1,2-d]pyrido[3,2-b][1,4]diazepine derivatives of formula (I) | 06-02-2011 |
Frauke Pohlki, Ludwigshafen DE
| Patent application number | Description | Published |
|---|---|---|
| 20100280014 | N-PHENYL- (PIPERAZINYL OR HOMOPIPERAZINYL)-BENZENESULFONAMIDE OR BENZENESULFONYL-PHENL-(PIPERAZINE OR HOMOPIPERAZINE) COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR - The present invention relates to N-phenyl-(piperazinyl or homopiperazinyl)-benzenesulfonamide or benzenesulfonyl-phenyl-(piperazine or homopiperazine) compounds, pharmaceutical compositions containing them, and their use in therapy. The compounds possess valuable therapeutic properties and are particularly suitable for treating diseases that respond to modulation of the serotonin 5-HT | 11-04-2010 |
| 20100292220 | BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR - The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT | 11-18-2010 |
| 20100292221 | BENZENESULFONANILIDE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR - The present invention relates to novel benzenesulfonanilide compounds of the formulae I and I′ and physiologically tolerated acid addition salts and the N-oxides thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT | 11-18-2010 |
Frauke Rininsland, Santa Fe, NM US
| Patent application number | Description | Published |
|---|---|---|
| 20080213747 | FLUORESCENT POLYMER SUPERQUENCHING-BASED BIOASSAYS - A chemical composition including a fluorescent polymer and a receptor that is specific for both a target biological agent and a chemical moiety including (a) a recognition element, (b) a tethering element, and (c) a property-altering element is disclosed. Both the fluorescent polymer and the receptor are co-located on a support. When the chemical moiety is bound to the receptor, the property-altering element is sufficiently close to the fluorescent polymer to alter the fluorescence emitted by the polymer. When an analyte sample is introduced, the target biological agent, if present, binds to the receptor, thereby displacing the chemical moiety from the receptor, resulting in an increase of detected fluorescence. Assays for detecting the presence of a target biological agent are also disclosed. | 09-04-2008 |
Frauke Rueffer, Seesen DE
| Patent application number | Description | Published |
|---|---|---|
| 20090130063 | PROCESS FOR SEPARATING AND DETERMINING THE VIRAL LOAD IN A PANCREATIN SAMPLE - Processes for separating a viral load from a pancreatin sample and for quantitatively determining the viral load in a pancreatin sample with high sensitivity are described herein. | 05-21-2009 |